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Molecular epidemiological studies have identified several risk factors linking to the genes
and external factors in the pathogenesis of breast cancer. In this sense, genetic instability
caused by DNA damage and DNA repair inefficiencies are important molecular events
for the diagnosis and prognosis of therapies. Therefore, the objective of this study
was to analyze correlation between sociocultural, occupational, and lifestyle risk factors
with levels of genetic instability in non-neoplastic cells of breast cancer patients. Total
150 individuals were included in the study that included 50 breast cancer patients
submitted to chemotherapy (QT), 50 breast cancer patients submitted to radiotherapy
(RT), and 50 healthy women without any cancer. Cytogenetic biomarkers for apoptosis
and DNA damage were evaluated in samples of buccal epithelial and peripheral blood
cells through micronuclei and comet assay tests. Elder age patients (61–80 years) had
higher levels of apoptosis (karyorrhexis by karyolysis) and DNA damage at the diagnosis
(baseline damage) with increased cell damage during QT and especially during RT.
We also reported the increased frequencies of cytogenetic biomarkers in patients who
were exposed to ionizing radiation as well as for alcoholism and smoking. QT and RT
induced high levels of fragmentation (karyorrhexis) and nuclear dissolution (karyolysis)
and DNA damage. Correlations were observed between age and karyorrhexis at
diagnosis; smoking and karyolysis during RT; and radiation and karyolysis during QT.
These correlations indicate that risk factors may also influence the genetic instability in
non-neoplastic cells caused to the patients during cancer therapies.
Keywords: breast cancer, risk factors, genetic instability, apoptosis, chemotherapy, toxicogenomics
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INTRODUCTION
The International Agency for Research on Cancer (IARC) and
the World Health Organization (WHO) published in the World
Health Report 2014 with the prediction of 27 million new cancer
cases by the year 2030 resulting in 17 million deaths and 75
million people living with cancer annually. Cancer is one of the
major public health problems worldwide (Vaidya et al., 2015;
Buyukavcu et al., 2016), occupying the second position of global
incidence (Buyukavcu et al., 2016). In Brazil, approximately
600,000 new cancer cases every year are estimated (INCA, 2016).
Breast cancer is a multifactorial disease with more incidences
in elderly patients (Arraras et al., 2016). According to
literature, more than 1.7 million cases are diagnosed worldwide
(Abdel-Zaher and Eldeib, 2016), where one in eight women
will probably develop breast cancer (Sismondi et al., 2015).
Recent data has pointed out the association between genetic
instability and cancer on the prognosis and disease progression
(Collins et al., 2014). The mechanisms associated are telomere
damage, centrosomal amplification, epigenetic modifications,
and genotoxic DNA damage. These genomic alterations may lead
to aneuploidy, induction of mutations, apoptosis, and necrosis
(Bonassi et al., 2011; Burrel and Swanton, 2014; Ferguson et al.,
2015). Several factors increased the risk of genetic instability
in cancer development such as age, endocrine/reproductive
history, behavioral/environmental factors, smoking, alcoholism,
exposure to ionizing radiation, and hereditary factors (Adami
et al., 2008; Mary et al., 2011; Buyukavcu et al., 2016).
Many cancer cells exhibited aneuploidies and chromosomal
alterations leading to genetic instability which is a hallmark
of cancer. Genetic heterogeneity is a problem for cancer
therapies especially therapies targeting specific molecules. Thus,
understanding the pathophysiology of genetic makeup is
required to advance the prevention and cure of cancer (Tanaka
and Hirota, 2016). Biomonitoring of molecular alterations can
be an important tool for better understanding of cancer biology
which not only secure more accurate diagnoses but also ensure
treatment success of cancer (Abramczyk and Brozek-Pluska,
2016). For this, the comet assay is increasingly being used for
the detection of genotoxicity (Enciso et al., 2015) as well as
the micronucleus test to evaluate chromosomal mutagenesis in
eukaryotes such as clastogenesis (loss of chromosome fragments)
and aneugenesis (loss or gain of whole chromosomes) and cell
death (Fenech and Bonassi, 2011).
Clinical and epidemiological studies are current priorities
for understanding breast cancer heterogeneity especially aspects
related to tumor etiology, chemoprophylaxis, and therapies,
which are important strategies to improve prevention, diagnosis,
prognosis and therapy efficacy (Barnard et al., 2015; Abdel-Zaher
and Eldeib, 2016). Thus, because of the influence of several risk
factors for the etiology of breast cancer as a confounding element
in genetic instability analysis induced during cancer therapies.
The present study aimed to evaluate the correlations between
sociocultural, occupational and life style risk factors with the
levels of genetic instabilities during the first diagnosis and during
chemotherapy (QT) and radiotherapy (RT). This study used
toxicological biomarkers as indicative of nuclear abnormalities
and genotoxicity in non-neoplastic cellular samples of the buccal
epithelium and peripheral blood of breast cancer patients.
MATERIALS AND METHODS
Individuals
All patients were informed of the procedures and provided a
written informed consent prior to sample collection. This study
was performed in compliance with the Helsinki Declaration and
was approved by the ethics committee of the Centro Universitário
UNINOVAFAPI, Brazil (approval number: 0406.0.043.000-11).
Between 2012 and 2015, 150 individuals were attended at
the São Marcos Hospital where 100 patients were diagnosed
with breast cancer including 83 with invasive ductal carcinoma
(83%), three with invasive lobular carcinoma (3%), three with
ductal carcinoma in situ (3%), three with medullary carcinoma
(3%), and three with phyllodes tumor (3%). A total of 50
healthy women were enrolled as controls. All breast cancer
patients were in between stage I and III based on TNM
staging system (TNM classification of malignant tumors). The
QT group of patients received two different QT protocols:
standard FAC QT (fluorouracil 500 mg/m2, doxorubicin
50 mg/m2, cyclophosphamide 500 mg/m2—all i.v.) or AC-T QT
(doxorubicin 50 mg/m2 and cyclophosphamide 500 mg/m2 i.v.)
for 21 days including 80 mg/m2 of docetaxel (Taxotere) weekly
for 12 weeks. Patients of RT group received 25 sessions of RT
isolated or after QT with a total dose of 4500–5000 cGy (180–
200 cGy/fraction). Breast cancer patients who presented renal
and liver dysfunctions were excluded from this study.
Sample Collection
Peripheral blood and buccal mucosa cells were samples and
processed on the same day. Four collections were performed in
breast cancer patients: (1) at the time of breast cancer diagnosis,
prior to treatment; (2) at the second cycle of QT; (3) at the
third week of QT; (4) at the fourth week of QT. Additionally,
four collections were performed during RT: (1) before the RT;
(2) at the second cycle of RT; (3) at the third week of QT;
(4) 21 days after the last RT session. Blood collection was
performed on the non-mastectomized side arm vein. For the
Micronucleus Test, samples of oral mucosa were obtained by
means of cytobrush brushes and stored in microtubes with 0.9%
saline, duly identified. The samples were kept under refrigeration
(4◦C) until processing of the Micronucleus Test and Comet
Assay at the Laboratory of Toxicological Genetics of the Federal
University of Piauí—UFPI which served as support for the
experiments.
Survey
The questionnaire for the International Commission for
Protection against Environmental Mutagens and Carcinogens
(ICPEMC) proposed by Carrano and Natarajan (1988) was
applied during the monitoring of cancer patients during
diagnosis and cancer therapies (QT and RT). The questionnaire
was related to various risk factors such as age, lifestyle,
environmental, and occupational exposure aspects, family
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history, diseases, and nutritional factors. It was adapted to meet
the needs of the study as well as to include information provided
by patients during anamnesis including the use of alternative
therapies as a therapeutic source during cancer treatment. The
various risk factors were observed according to their frequencies
and statistically correlated with genetic instability biomarkers
such as DNA damage and apoptosis in non-neoplastic cells of
patients before and during QT and RT.
Genomic Instability Analysis
Comet Assay in Peripheral Blood Cells
After blood collection, samples were immediately processed
according to Singh et al. (1988) with modifications. The results
were expressed as damage index (DI) and frequency of damage
(DF). The DI was obtained by evaluating the tail type which was
classified from 0 to 4 (50 cells per slide in duplicate, i.e., 100
per individual). Class 0 (C0, genetic material without damage or
intact); class 1 (C1, mild damage); class 2 (C2, moderate damage);
class 3 (C3, severe damage); and class 4 (C4, maximum damage).
In order to determine DI, the total score for each individual
was between 0 and 400 arbitrary units, and was defined as: DI:
0 × (C0) + 1 × (C1) + 2 × (C2) + 3 × (C3) + 4 × (C4).
Each image was scored according to the extent of DNA migration
based on a visual analysis in 100 cells of each slide. The DF
analysis, varying from 0 to 100 (%), was define as: DF= 100−C0,
in which C0 represents the number of class 0 cells out of 100 cells
evaluated.
Micronucleus Test in Buccal Epithelial Cells
The micronucleus test in buccal epithelial cells was performed
according to Thomas et al. (2009). The incidence of micronuclei
and nuclear abnormalities representing cell death (karyorrhexis
and karyolysis) were observed in 2000 cells per patient using
an optical microscope (Olympus, CX, United States) at 1000×
magnification.
Statistical Analysis
Statistical analysis was performed using SPSS version 13.0 (IBM
Corp., Armonk, United States) for the analysis of variance
with the non-parametric one-way ANOVA test and Spearman
correlations. Kruskal–Wallis test was used to compare the
hematological and biochemical parameters and the Student’s
t-test for comparisons between the exposed and non-exposed
individuals in the genotoxic evaluation. Significance levels of up
to p < 0.05 were adopted.
RESULTS AND DISCUSSION
Patients Characteristics
Socioeconomic factors, environmental and behavioral risks,
psychosocial, educational and occupational aspects, lifestyle and
stress levels have influenced the risk of breast cancer (Mary et al.,
2011; Peretti-Watel et al., 2016). Ethnicity is an important factors
for the etiology of breast cancer (Chen et al., 2002). As observed in
the study, the vast majority (70–80%) of cancer patients reported
were of Caucasian ethnicity (Table 1). Studies indicate that the
TABLE 1 | Sociocultural characterization of occupational risks, lifestyle for breast









Caucasian 50% 78%∗ 82%∗
Black 34% 22% 16%
Other 16% – 2%
Agea 48.3 ± 13.4 49.8 ± 10.6 50.4 ± 11.9
Occupational risks
Working time
1–2 years 8% 6% 6%
2–4 years 14% 6% –
4–8 years 6% 4% 6%
More than 8 years 72% 84% 88%
Working place
Home 64% 62% 48%
School 24% 14% 16%
Farm 12% 24% 36%∗
Chemical exposure
Agrotoxics – 28%∗ 24%∗
Formalin – 10% 18%
Others – 38% 24%
None 100% 24% 30%
Detergent exposure
Yes – 92% 86%
No – 8% 14%
Hypochlorite exposure
Yes 98% 86% 80%
No 2% 14% 20%∗
Life style
Smoke
Yes – 46% 48%
No 100% 54% 52%
Alcohol
Yes – 28% 24%
No 100% 72% 76%
X-ray exposure
Yes 32% 90%∗ 100%∗
No 68% 10%
aValues are the mean ± standard deviation. ∗p < 0.05 compared to the control
group.
incidence of breast cancer is 124 cases per 100,000 white women
and 113 cases per 100,000 black women (American Cancer
Society [ACS], 2009).
Reproductive age involving events like menarche, menopause
and pregnancy, hormone therapy confers risks that can trigger
neoplasms (Patterson et al., 2013) and estrogen alterations
(Monninkhof et al., 2009).
As observed in the present study, the mean age of the patients
was 50 years, with no statistical differences between the groups.
An earlier case study on Korean women (n = 1026) indicated
that the mean age of breast cancer diagnosis was 46.8 years
with 14.4 and 26.3 as the age of menarche and first parturition
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(Kang et al., 2014). However, other studies indicated that 2–
20% of women diagnosed with breast cancer were under the
age of 35 years with tumors that present aggressive biological
behavior resulting in mortality and metastasis (Kallel et al., 2015).
Moreover, women’s reproductive life, precocious menarche,
nulliparity, age of first gestation over 30 years, oral contraceptives,
late menopause, and hormone replacement therapy are also well
established in relation to breast cancer development (Thuler,
2003; Pinho and Coutinho, 2007; Brasil, 2008, 2009). Although
it is not well documented whether race and cultural differences
impart differently on breast cancer induction and progression, yet
these factors may have individual roles.
Breast cancer patients are also reported to have exposure
to various genotoxic and carcinogenic agents in their domestic
activities (detergents and hypochlorites) and occupational
contaminants (pesticide) as well as exposure to ionizing radiation
before and after diagnosis. Ionizing radiation leads to mutations
due to increased chromosomal aberrations and alterations
in DNA repair (Mozdarani, 2012) as well as RT-associated
alterations including circulatory problems and secondary cancer
(Hamada and Fujimichi, 2014). Approximately 50% of RT
patients also reported with a smoking habit which is an identified
carcinogenic agent with evident increased risk of breast cancer in
humans (International Agency for Research on Cancer [IARC],
2015). Similar data (30%) were observed for the consumption of
alcoholic beverages, even moderately, may be associated with the
risk of breast cancer (Thuler, 2003).
Association between Age and Genetic
Instability as an Indicative of Apoptosis
and Genotoxicity
Before the cancer treatment as well as during RT, nuclear
abnormalities (cell death) were statistically increased in patients
between 20 and 40 years of age when compared to others.
Similar results were found in the range of 41–60 years in
relation to the range of 61–80 years age groups indicating that
the younger patients are more likely for apoptosis during RT
(Table 2). Positive correlations were observed at the basal level
between karyorrhexis and age in non-neoplastic cells of the
buccal epithelium. Exposure to RT is also not selective with the
risks of reaching non-neoplastic tissues (Chan et al., 2005; Taylor
and Kirby, 2015). Although the benefits of cancer therapy are
inquestionable, the safety aspects cannot be ignored, since these
drugs’ mechanisms of action can have harmful effects on different
tissues (Adão et al., 2012).
During RT and QT, significant increases of karyorrhexes
were observed in the buccal epithelium of older patients.
Patients with RT showed significant increase in cell death in
buccal epithelium as compared to patients undergoing QT.
The age in association with hormone receptors status, family
history, and genetic aspects may have implications on cancer
therapies (Peto and Mack, 2000; Pinho and Coutinho, 2007;
Lizarraga et al., 2013). Previous studies have shown that
young women with triple negative breast tumors have worst
prognosis regarding recurrence and mortality (Kallel et al., 2015;
Reviriego et al., 2016). Endocrine factors/reproductive history
is mainly related to estrogen stimulation whether endogenous
or exogenous, pregnancy after 30 years, nulliparity, use of oral
contraceptives (estrogen–progesterone), and postmenopausal
hormone replacement therapy (estrogen–progesterone) are all
associated with breast cancer incidence (International Agency for
Research on Cancer [IARC], 2015; World Health Organization
[WHO], 2015).
During cancer development, several pathways may cause
genetic instability leading to cell proliferation, inflammation,
immune response alterations, and resistance to apoptosis.
Genetic instability may induce replicative immortality, cell cycle
abnormalities, aneuploidy, and tetraploidy (Ferguson et al.,
2015; Asatryan and Komarova, 2016). The genotoxic damage
observed in lymphocytes from RT patients was also significant
(p < 0.05) as compared to those observed on lymphocytes
from patients during QT as well as from baseline and control
group (Table 2). No significant statistical differences were
observed between the age ranges in relation to genotoxic damages
observed. Increased levels of DNA damage and inefficient repair
mechanisms are molecular events of many pathogens including
cancer (Gunasekarana et al., 2015). Detection of DNA damage
is an initial step toward understanding cellular responses to
genotoxic events. Then it is important to know the relationship
between drug genotoxicity and checkpoint adaptation during
DNA damage mitosis (Swift and Golsteyn, 2014).
Correlations between Occupational
Risks and Genetic Instabilities As
Indicative of Apoptosis and Genotoxicity
Nuclear abnormalities as indicative of cell death in the oral
epithelium, especially for karyorrhexis, showed increased levels
in patients from QT and RT groups as compared to control. The
karyorrhexes observed for domestic occupation were significant
in relation to the risks of school and agricultural activities
especially for patients in RT. Cell death observed in RT group
was also significant in relation to QT group (Table 3). Previous
studies have reported that occupational exposure to pesticides has
effects on the frequency of micronuclei in oral mucosal cells with
cytogenetic damage in somatic cells and correlations between
some genotoxicity biomarkers (Bolognesi, 2003; Celik and Akbas,
2005). According to Rudel (2007), occupational exposure to
chemicals in women involved in agriculture and/or industry
should be monitored in epidemiological studies.
Basal genotoxic damages of lymphocytes in patients before
QT and RT were statistically significant as compared to control.
Likewise, patients with RT showed more genotoxic lymphocyte
damage that QT patients. QT patients exposed to agricultural
activities showed significant increase in genotoxic damage as
compared to patients with home and school activities. However,
this significance was not observed in the genotoxic damage
to the lymphocytes of patients in radiotherapies (Table 3).
Lymphocytes isolated from peripheral blood and exfoliated cells
of the buccal epithelium are used to determine the effects of
mutagens based on cytogenetic markers such as chromosomal
aberrations, micronuclei, chromatid breaks, and comet assay
(Faust et al., 2004; Hoffmann and Speit, 2005).
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TABLE 2 | Correlation of age with cell death (buccal epithelium) and genotoxicity (lymphocytes).
Cytogenetic damage Control Basal Chemotherapy Radiotherapy
Buccal epithelium
Karyorrhexis R = −0.479∗∗ (p = 0.010)
20–40 years 183.9 ± 77.6 250.0 ± 97.0ae 319.1 ± 90.9af 516.1 ± 152.0abef
41–60 years 165.0 ± 103.3 276.6 ± 120.0acde 397.5 ± 121.9acf 509.7 ± 128.3abef
61–80 years 184.1 ± 104.4 222.0 ± 32.0ac 386.1 ± 189.3acf 419.2 ± 153.1abf
Karyolysis
20–40 years 56.5 ± 27.2 87.6 ± 48.2a 93.4 ± 63.3a 381.9 ± 147.5abdef
41–60 years 50.6 ± 35.5 94.4 ± 47.9a 81.3 ± 37.7a 162.2 ± 67.3abef
61–80 years 73.0 ± 43.2 56.0 ± 21.0a 68.6 ± 22.7a 220.0 ± 151.8abcdf
Lymphocytes
Damage index
20–40 years 19.9 ± 8.2 199.2 ± 41.8a 181.1 ± 60.7a 218.1 ± 21.6abf
41–60 years 34.7 ± 16.4 178.2 ± 50.4a 185.7 ± 47.4a 204.5 ± 42.9abf
61–80 years 21.1 ± 10.6 193.4 ± 39.7a 179.7 ± 49.5a 215.9 ± 38.2abf
Frequency of damage
20–40 years 14.4 ± 4.8 79.4 ± 19.1 90.0 ± 7.0 94.2 ± 7.8ab
41–60 years 16.8 ± 5.9 79.5 ± 18.5 90.0 ± 10.2 88.4 ± 6.9ab
61–80 years 14.8 ± 6.4 70.0 ± 13.5 87.2 ± 8.2 96.2 ± 2.5ab
Values represent the mean ± standard deviation. Significance up to p < 0.05. aCompared to the control group. bCompared to the chemotherapy group. cCompared to
the age of 20–41 years. dCompared to the age of 41–60 years. eCompared to the age of 61–80 years. fCompared to baseline level. ∗∗p values as compared to control
group.
TABLE 3 | Correlation of occupational risks with cell death (buccal epithelium) and genotoxicity (lymphocytes).
Cytogenetic damage Control Basal Chemotherapy Radiotherapy
Buccal epithelium
Karyorrhexis
Home 184.8 ± 66.3d 248.1 ± 69.8acd 368.4 ± 64.2a 391.5 ± 68.5ab
School 187.7 ± 53.4d 224.8 ± 37.8a 378.5 ± 72.2a 468.6 ± 65.9ab
Agricultural activity 147.2 ± 75.2 340.3 ± 74.4a 379.9 ± 77.8a 428.4 ± 75.7abe
Karyolysis
Home 55.3 ± 39.8 94.7 ± 68.3a 98.1 ± 58.2ac 175.1 ± 69.3abe
School 50.0 ± 36.5 113.4 ± 34.2ae 56.1 ± 43.4a 174.5 ± 55.9ab
Agricultural activity 67.0 ± 37.9 85.5 ± 66.6a 90.4 ± 50.8ac 177.5 ± 89.9abe
Lymphocytes
Damage index
Home 26.2 ± 14.1 139.7 ± 58.8ac 193.9 ± 48.1ac 189.8 ± 62.9a
School 17.2 ± 8.7d 181.2 ± 73.0ad 231.7 ± 68.0ad 220.6 ± 64.2a
Agricultural activity 41.0 ± 21.9 138.5 ± 60.3a 178.4 ± 48.3a 215.2 ± 72.2ab
Frequency of damage
Home 15.8 ± 10.2 72.4 ± 17.3ac 90.5 ± 11.0a 86.5 ± 12.7a
School 12.6 ± 5.2 91.4 ± 14.2a 91.5 ± 12.4a 93.2 ± 7.7a
Agricultural activity 19.6 ± 8.8 80.5 ± 17.0a 89.2 ± 10.4a 89.3 ± 17.2a
Values represent the mean ± standard deviation. Significance up to p < 0.05. aCompared to the control group. bCompared to the chemotherapy group. cCompared to
individuals who answered “school.” dCompared to individuals who answered “agriculture.” eCompared to baseline damage.
Association between Smoking and
Genetic Instability As Indicative of Cell
Death and Genotoxicity
Nuclear abnormalities in patients with smoking habit prior to
breast cancer diagnosis were significantly increased during QT
and RT at baseline and during treatment (Table 4). Smoking can
induce significant changes in DNA, as indicated by cytogenetic
biomarkers, and increases the risk of cancer by elevating levels of
micronuclei in buccal mucosa epithelial cells (Celik et al., 2003;
Celik and Akbas, 2005). However, smoking did not significantly
influence the DI and DF in lymphocytes in QT patients with
reported smoking. However, RT patients showed increase in the
genotoxicity parameters as compared to QT patients in relation
to non-smokers before the diagnosis for breast cancer.
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Yes 289.0 ± 79.6b 367.2 ± 63.0b 485.6 ± 81.0abc
No 239.1 ± 67.8 285.2 ± 72.1 451.3 ± 76.3ac
Karyolysis r = 0.411∗ (p = 0.003)
Yes 86.2 ± 51.0 94.7 ± 61.3 293.3 ± 82.0abc
No 86.9 ± 54.8 105.3 ± 56.2 124.1 ± 69.6a
Lymphocytes
Damage index
Yes 152.8 ± 67.1 197.7 ± 58.6 208.4 ± 56.1c
No 145.7 ± 50.3 181.3 ± 57.4 214.9 ± 66.9a
Frequency of damage
Yes 78.1 ± 20.1 88.7 ± 11.4 92.4 ± 8.5
No 81.2 ± 17.3 91.7 ± 8.8 88.8 ± 15.9
Values represent the mean ± standard deviation. Significance up to p < 0.05.
aCompared to the chemotherapy group. bCompared to individuals who answered
“no.” cCompared to baseline damage. ∗p values as compared to control group.
FIGURE 1 | Correlation between smoking and karyolysis in buccal epithelium
of breast cancer patients during radiotherapy. Spearman’s correlation
∗p < 0.05.
Smoking, a factor studied over the years with contradictory
results, is currently recognized by the IARC as a carcinogenic
agent with evidence of increased risk of breast cancer in humans
(International Agency for Research on Cancer [IARC], 2015).
Genotoxic evaluation using comet assay showed significant
differences among smokers, non-smokers, and passive smokers,
demonstrating induction of oxidative damages (Zalata et al.,
2007). Positive correlations were observed between smoking and
karyolysis in patients during RT (Figure 1). Moreover, studies
also indicated the genotoxic effects of tobacco on oral epithelium
(Tolbert et al., 1992; Trivedi et al., 1993) and mutagenic effects
by micronuclei, karyorrhexis, karyolysis, and binucleate cells
(Ergene et al., 2007). However, numerous reports indicate that
there are no associations between smokers and increased DNA
migration in peripheral lymphocytes of smokers of more than 20
cigarettes per day (Speit et al., 2003, 2007).
Correlations between Smoking and
Genetic Instability As Indicative of Cell
Death and Genotoxicity in Breast Cancer
Patients
Patients on QT and RT with alcohol consumption showed
increased apoptosis levels in the buccal epithelium. Radiation
therapy also increased the levels of biomarkers. Patients who
reported consumption of alcoholic beverages at the baseline level
did not show increase in DI and DF. However, during QT, these
damages were significantly increased in patients who did not
consume alcohol. No correlation was observed between ethylism
and the cytogenetic biomarkers evaluated (Table 5). There is
still limited evidence of smoking with the risk for breast cancer
(Ghissassi et al., 2009; Secretan et al., 2009).
Alcohol consumption is positively associated with breast
cancer in menopausal women with more than 10 g/day (Lew
et al., 2009). In postmenopausal women, there are associations
between lifestyle (consumption of alcohol and tobacco) and
inadequate diet with breast cancer. Thus, breast cancer preventive
measures include no alcohol consumption (or only moderate),
healthy diet, and physical activity (McKenzie et al., 2015).
Interactions between lifestyle and dietary factors with genes
are pointed out, for instance, the association with the MAPK
genes such as MAPK 14 (p38) which may interact with alcohol,
diet and lifestyle (Slattery et al., 2014). Although the biological
mechanism has not yet been well elucidated, there is proven
evidence that alcohol induces chromosomal instability resulting
in aneuploidy events which are associated with cancer. In
addition, the induction of oxidative damage, DNA adducts,
crosslinks and DNA strand breaks can result in reactive oxygen
species, lipid peroxidation product and acetaldehyde (Bonassi
et al., 2011; Fenech and Bonassi, 2011). Interestingly the







Yes 271.8 ± 93.5b 333.7 ± 83.1b 562.9 ± 79.3abc
No 212.1 ± 76.9 393.7 ± 82.7 439.5 ± 97.1a
Karyolysis
Yes 109.7 ± 65.7b 123.1 ± 80.2b 219.2 ± 53.1abc
No 79.0 ± 46.7 91.6 ± 63.1 189.6 ± 87.8a
Lymphocytes
Damage index
Yes 147.5 ± 63.5 192.1 ± 59.8b 201.3 ± 45.1
No 149.5 ± 56.8 169.2 ± 32.1 215.1 ± 65.9a
Frequency of damage
Yes 79.8 ± 19.2 89.3 ± 10.8 93.9 ± 4.7
No 77.7 ± 18.5 90.7 ± 9.9 89.5 ± 14.4
Values represent the mean ± standard deviation. Significance up to p < 0.05.
aCompared to the chemotherapy group. bCompared to individuals who answered
“no.” cCompared to baseline damage.
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TABLE 6 | Correlation of ionizing radiation with cell death (buccal epithelium) and genotoxicity (lymphocytes).
Cytogenetic damage Control Basal Chemotherapy Radiotherapy
Buccal epithelium
Karyorrhexis
Yes 172.3 ± 79.4c 250.9 ± 87.3a 355.2 ± 81.4ad 469.1 ± 169.7abd
No 154.8 ± 84.2 – 346.6 ± 73.9a –
Karyolysis R = 0.298∗ (p = 0.042)
Yes 58.7 ± 45.0 86.7 ± 52.5a 107.5 ± 86.4acd 210.9 ± 83.2abd
No 45.3 ± 22.3 – 50.2 ± 15.5 –
Lymphocytes
Damage index
Yes 23.5 ± 18.1 157.0 ± 56.9ac 191.2 ± 56.9ac 211.8 ± 61.4a
No 29.1 ± 23.9 87.8 ± 25.3a 151.0 ± 29.7a –
Frequency of damage R = 0.279∗ (p = 0.050) R = 0.391∗∗ (p = 0.005)
Yes 14.7 ± 7.9 81.7 ± 18.7ac 91.6 ± 9.8a 90.6 ± 12.9a
No 16.3 ± 9.7 62.4 ± 5.7a 82.0 ± 7.7a –
Values represent the mean ± standard deviation. Significance up to p < 0.05. aCompared to the control group. bCompared to the chemotherapy group. cCompared to
individuals who answered “no.” dCompared to baseline damage levels. ∗, ∗∗p values as compared to control group.
moderate consumption of alcohol reduced the risk of breast
cancer by about 30% (Colditz and Bohlke, 2014; Howell et al.,
2014).
Correlations between Ionizing Radiation
and Genetic Instability As Indicative of
Cell Death and Genotoxicity
Patients were also reported to exposure of ionizing radiations
(Table 1). At baseline, nuclear abnormalities of the buccal
epithelium of patients who underwent RT and QT were
significantly increased as compared to the control. RT also
induced more cell death (karyorrhexis and karyolysis) when
compared to QT. Positive correlations were observed between
exposure to ionizing radiation and cell death by karyolysis in
patients during QT as well as for DF at baseline and during QT as
well (Table 6).
Ionizing radiations are known to increase cancer risk
(Preston et al., 2007; Kaiser et al., 2012) especially in patients
undergoing further medical examinations (Kaiser et al., 2012). RT
significantly increases DNA damage in lymphocyte in relation to
QT and causes damage to repair genes (Synowiec et al., 2008).
Exposure to X-rays induces significant increase in genotoxicity
parameters (DI and DF) in peripheral blood lymphocytes of
breast cancer patients compared to baseline levels in controls
(Table 6). Ionizing radiation induces DNA damage and is known
to be carcinogenic as it can cause DNA strand breaks as well
as chromosomal rearrangements (Bekker-Jensen and Mailand,
2010). Double strand breaks are the most deleterious lesions
induced by ionizing radiations which can lead to cell death due to
their acute toxicities (Barnard et al., 2013). In addition to strand
breaks, ionizing radiations induce damage to the chromosomal
DNA, abasic sites, base and sugar oxidations, and cross-links
(Eccles et al., 2011).
Exposure of DNA to radiation induces a signal transduction
cascade resulting in damage to the genetic material, DNA
strand breaks, including increased reactive oxygen species
(Mantena et al., 2008; Mello et al., 2011; Taylor and Kirby,
2015), and induction of chromosomal aberrations and apoptosis
(Szumiel and Foray, 2011). Tumor suppressor genes such as
p53 and PTEN can be deregulated resulting in impairment of
important functions such as induction of apoptosis, activation
of the repair system and cell cycle arrest (Heinloth et al., 2003).
RT increases the survival rate in cancer patients (Gentile et al.,
2015) but may lead to clinical complications (Taylor and Kirby,
2015.) like genetic instability (Eidemüller et al., 2015). The effects
and low doses of radiation are still uncertain but in women with
germline mutations in BRCA1 and BRCA2 genes, an association
with radiological diagnoses exists especially after 50 years of age
(John et al., 2013).
CONCLUSION
At the baseline, breast cancer patients already showed increased
DNA damage in the oral epithelium (karyorrhexis and karyolysis)
and lymphocytes (DI and DF) in relation to the control
group. Our result indicating genetic instability were significantly
increased during cancer therapies (QT and RT). The cytogenetic
damages assessed during RT were bigger than those evidenced
during QT. Cytogenetic damages were differentiated for risk
factors (age, workplace, smoking, alcoholism, and exposure to
X-rays) for genetic instability. Considering the age as risk factor
for nuclear abnormalities indicative of cell death (karyorrhexis
and karyolysis) were more evident in younger women and during
the menopausal period as compared to women aged over 60
years. Negative correlations were found between age and nuclear
abnormalities at the baseline level. These relationships were
not observed for genotoxic damage in lymphocytes. Patients
who reported smoking habit presented more karyorrhexis
and karyolysis in the buccal epithelium; and genotoxicity in
lymphocytes before (baseline) and during QT and RT. However,
positive correlations were evidenced only between smoking and
karyolysis for patients undergoing RT.
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